Arrowhead Pharmaceuticals, Inc. (ARWR)

NASDAQ: ARWR · Real-Time Price · USD

13.82

+0.02 (0.14%)

At close: Mar 28, 2025, 4:00 PM

13.54

-0.28 (-1.99%)

Pre-market: Mar 31, 2025, 8:55 AM EDT

Arrowhead Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Mar '25 Mar 28, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2019 - 2015
Market Capitalization	1,743	2,408	2,880	3,498	6,509	4,405	Upgrade
Market Cap Growth	-28.84%	-16.40%	-17.67%	-46.25%	47.77%	64.01%	Upgrade
Enterprise Value	2,064	2,436	2,799	3,183	6,017	4,138	Upgrade
Last Close Price	13.82	19.37	26.87	33.05	62.43	43.06	Upgrade
PS Ratio	697.07	678.12	11.96	14.38	47.07	50.06	Upgrade
PB Ratio	33.00	12.60	10.03	8.36	15.92	9.54	Upgrade
P/TBV Ratio	52.63	13.61	11.03	9.05	16.47	9.87	Upgrade
P/FCF Ratio	-	-	-	44.06	-	Upgrade
P/OCF Ratio	-	-	-	37.99	-	Upgrade
EV/Sales Ratio	825.55	686.02	11.63	13.09	43.51	47.03	Upgrade
EV/FCF Ratio	-	-	-	40.72	-	Upgrade
Debt / Equity Ratio	15.55	4.46	1.34	0.20	0.06	0.05	Upgrade
Debt / FCF Ratio	-	-	-	-	0.17	-	Upgrade
Asset Turnover	0.00	0.00	0.33	0.35	0.22	0.20	Upgrade
Quick Ratio	5.90	6.57	3.75	2.67	2.58	7.78	Upgrade
Current Ratio	6.09	6.74	3.95	2.92	2.63	7.92	Upgrade
Return on Equity (ROE)	-565.33%	-254.98%	-59.33%	-42.68%	-32.36%	-23.96%	Upgrade
Return on Assets (ROA)	-47.71%	-39.43%	-17.58%	-15.91%	-15.11%	-13.35%	Upgrade
Return on Capital (ROIC)	-52.37%	-43.84%	-21.89%	-23.88%	-20.31%	-16.02%	Upgrade
Earnings Yield	-36.71%	-24.90%	-7.13%	-5.03%	-2.16%	-1.92%	Upgrade
FCF Yield	-32.80%	-25.10%	-11.48%	-5.40%	2.27%	-2.45%	Upgrade
Buyback Yield / Dilution	-15.92%	-12.21%	-1.26%	-1.62%	-3.00%	-2.14%	Upgrade

Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q